Transmethylation Processes in Schizophrenia
It is generally agreed today that the etiology of schizophrenia is compounded of a genetically determined predisposition, in the form of some vulnerable enzyme system or systems in the brain possibly concerned with reactions to stress, together with various environmental factors that determine whether the genotype is actually expressed as the phenotype. There is very little information, however, on what the biochemical lesion is, and only a handful of hypotheses about what the lesion could be. The so-called transmethylation hypothesis is based on the observation made in 1950 by Harley-Mason, Osmond, and Smythies that mescaline is an O-methyl derivative of dopamine. Many other psychotomimetic drugs have been discovered since then, and most of these are either O-methyl, or N-methyl (or both) derivatives of the central neurotransmitters, noradrenaline, dopamine and serotonin.
KeywordsSchizophrenic Patient Anion Exchange Resin Blow Down Isobutyl Methyl Ketone Brain Serotonin
Unable to display preview. Download preview PDF.
- Antun, F.; Burnett, G.; Cooper, A. J.; Daly, R. J.; and Smythies, J. R. 1971. J. Psychiat. Res. in press.Google Scholar
- Mandell, A. J.; Buckingham, B.; and Segal, D. 1971. Behavioral, metabolic, and enzymatic studies of a brain indoleethylamine N-methylating system. This volume.Google Scholar
- Rosenthal, D., and Kety, S. (eds.) 1968. The Transmission of Schizophrenia. Oxford: Pergaman Press.Google Scholar
- Smythies, J. R. 1970. Brain Mechanisms and Behaviour. Oxford: Blackwell.Google Scholar
- Smythies, J. R. 1971. The chemical anatomy of synaptic mechanisms. Int. Rev. Neurobiol. vol. 14, in press.Google Scholar
- Smythies, J. R., and Antun, F. 1970. The biochemistry of psychosis. Scottish Med. J. 15:34.Google Scholar